O
Oculogica
Innovative eye-tracking technology for accurate concussion diagnosis without baseline tests
About Oculogica
Oculogica is a pioneering medical device company specializing in concussion diagnosis through advanced eye-tracking technology. The company's flagship product, EyeBOX, is the first FDA-cleared concussion assessment tool that does not require a baseline test, making it a significant breakthrough in the field. Oculogica serves a diverse range of clients, including sports organizations, healthcare providers, and medical professionals, addressing the critical need for objective and accurate concussion diagnostics. Operating in the medical technology market, Oculogica's business model revolves around the sale and distribution of its diagnostic devices, along with providing ongoing technical support and regulatory compliance services. Revenue is generated through direct sales, partnerships, and potentially through licensing agreements. The company's commitment to high standards and continuous improvement ensures that it meets the regulatory requirements and customer expectations effectively.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- New Richmond, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 78.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Neurology, Spinout, Biotech and Pharma, Woman Founder, medical testing, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | May 2024 | $7.6M | $41M | Undisclosed | ↗ |
| EARLY VCOther financing | Jun 2022 | $2M | $25M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Oculogica is 2.7K monthly website visits, up 8% over the last three months. Oculogica's team grew 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Nebraska Angel Network
Small Business Innovation Research
Series A2 investors entered at this stage
Daren Cotter
TitletownTech
Other known investors6 additional known investors
University of Minnesota Medical School
Colle Capital Partners
Quark Venture
Sofia Fund
Southeast Minnesota Capital Fund
StartX
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oculogica on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oculogica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.